Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Power List / 2018 / Honorees / Sheraz Daya

Sheraz Daya

  • Profile

About Sheraz Daya

Sheraz Daya

Medical Director, Centre for Sight, East Grinstead, UK

Sheraz was amongst the first in the UK to perform LASIK, and he has pioneered a number of corneal and anterior segment techniques and invented several ophthalmic instruments.

What motivates you?

“It’s really curiosity that motivates me – asking a question or encountering a problem, and then going out there to find the solution. I have a considerable dislike for dogmatic thinking and process and confess that when I find flaws, I do challenge them using fundamentals as a basis.”

What’s the future of corneal transplantation?

“Corneal transplantation has changed considerably over the last 15 years and many of those changes are thanks to technology derived from refractive surgery! Microkeratomes enabled Descemet’s stripping endothelial keratoplasty (DSAEK), which ended up evolving into Descemet’s membrane endothelial keratoplasty (DMEK). I expect both procedures will be replaced by therapeutic modalities, such as corneal cell therapies with Rho Kinase inhibitors. Stromal substitutes are already in development and I expect synthetic corneas will become more commonplace. Stem cell treatments will have a role, so long as the correct concoction of cytokines and growth factors can be found to get stem cells recruited from the bone marrow and provide the necessary repairs required.”

Resurrecting the Cornea

Ignore the Gurus and Follow the Evidence

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: